Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka
Dermatology · 2025
DOI: 10.1159/000539336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, 2025. Verfasst von Kanchana Viraj Mallawaarachchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Base Hospital - Balangoda, Balangoda, Sri Lanka. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicles in the apocrine gland-bearing areas of the body. The global HS prevalence has been reported in the range of 0.00033–4.1%. It is reportedly rarer in Asia.
Methods
The study aimed to establish the prevalence of hidradenitis suppurativa (HS) in a Sri Lankan hospital setting. An explorative, cross-sectional, descriptive study was done on a sample of accompanying healthy persons to patients at Base Hospital, Balangoda, Sri Lanka. The study was conducted over a 6-month period (November 1st, 2022, to April 30th, 2023) and was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The data were collected using validated self-administered questionnaire. When the questionnaire indicated HS (screen-positive), the study participant was referred to the consultant dermatologist, who examined the individual and confirmed the final diagnosis based on three obligatory diagnostic criteria (i.e., typical lesion, typical topography, and the chronicity and recurrence).
Results
Of 993 participants, the prevalence of HS was 0.2 (95% confidence interval 0.06%–0.73%). The difference in median age between two groups (i.e., individuals with HS – positive group and the control group) was statistically significant (p = 0.01802). The HS group was relatively younger with a median age of 26.5 (23.8–29.3) years, while that of the control group was 54.0 (48.0–59.0).
Conclusion
Hidradenitis suppurativa is rare in Sri Lanka as in other Asia-pacific countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Base Hospital - Balangoda, Balangoda, Sri Lanka.
- Department of Pediatrics, Base Hospital - Balangoda, Balangoda, Sri Lanka.
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
- Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
- Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
Zitieren
APA
Mallawaarachchi, K. V., Gangani, C., Bouazzi, D., Medianfar, C. E., Christensen, R., & Jemec, G. B. E. (2025). Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka. Dermatology. https://doi.org/10.1159/000539336
Vancouver
Mallawaarachchi KV, Gangani C, Bouazzi D, Medianfar CE, Christensen R, Jemec GBE. Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka. Dermatology. 2025. doi:10.1159/000539336
BibTeX
@article{Mallawaarachchi2025,
author = {Mallawaarachchi, Kanchana Viraj and Gangani, Chathurika and Bouazzi, Dorra and Medianfar, Cecilia E and Christensen, Robin and Jemec, Gregor B E},
title = {Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka},
journal = {Dermatology},
year = {2025},
doi = {10.1159/000539336}
}
EUVIMED